CD40-antigen-stimulant (IcanoMAB)

N/A

Report date: 2024/11/04 16:01:01

Base Information

Drug NameCD40-antigen-stimulant (IcanoMAB)
Drug Alias NameCD40 agonist (IcanoMAB)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT lymphocytes stimulantsTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsSolid tumoursInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcanoMAB GmbH
China Registration ClassN/A

Develop Information

Active CompaniesIcanoMAB GmbH
Inactive CompaniesN/A
Active IndicationsSolid tumoursInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A